PedAM
Pediatric Disease Annotations & Medicines
| Disease | constipation |
| Phenotype | |irritable bowel |
| Sentences | 57 |
| PubMedID- 24623286 | The high number of constipation predominant irritable bowel syndrome and very low number of diarrhea predominant irritable bowel syndrome patients might be the reason for statistical non-significance since alpha2-adrenergic receptor gene is found to be responsible for mediating intestinal antisecretory action and probably is involved in the pathogenesis of diarrhea predominant irritable bowel syndrome. |
| PubMedID- 24840367 | irritable bowel syndrome with constipation and chronic functional constipation are common digestive disorders that negatively impact quality of life and account for billions of dollars in health care costs. |
| PubMedID- 25781368 | Introduction: the irritable bowel syndrome with constipation (ibs-c) and chronic idiopathic constipation (cic) are associated with substantial symptom and disease burden. |
| PubMedID- 25538778 | The effect of biofeedback therapy on dyssynergic constipation in patients with or without irritable bowel syndrome. |
| PubMedID- 25237424 | Background: irritable bowel syndrome with constipation (ibs-c), a chronic functional gastrointestinal disorder, has been shown to negatively affect work productivity and impair daily activity, resulting in a substantial burden for patients and employers. |
| PubMedID- 26533548 | The burden of moderate-to-severe irritable bowel syndrome with constipation (ibs-c) in france: a comparison with the european results from the ibis-c observational study. |
| PubMedID- 24090017 | The european medicines agency has authorized its indication for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation in adults. |
Page: 1 2